Cargando…
Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein
Gliflozins (inhibitors of sodium-glucose cotransporter 2) show many beneficial actions beyond their antidiabetic effects. The underlying mechanisms of these additional protective effects are still not well understood, especially under non-diabetic conditions. Therefore, we analyzed the effects of em...
Autores principales: | Malínská, Hana, Hüttl, Martina, Marková, Irena, Miklánková, Denisa, Hojná, Silvie, Papoušek, František, Šilhavý, Jan, Mlejnek, Petr, Zicha, Josef, Hrdlička, Jaroslav, Pravenec, Michal, Vaněčková, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495591/ https://www.ncbi.nlm.nih.gov/pubmed/36140169 http://dx.doi.org/10.3390/biomedicines10092066 |
Ejemplares similares
-
In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia
por: Hüttl, Martina, et al.
Publicado: (2021) -
Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model
por: Hüttl, Martina, et al.
Publicado: (2023) -
Hypolipidemic Effects of Beetroot Juice in SHR-CRP and HHTg Rat Models of Metabolic Syndrome: Analysis of Hepatic Proteome
por: Šilhavý, Jan, et al.
Publicado: (2023) -
Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease
por: Hojná, Silvie, et al.
Publicado: (2022) -
Hepatic Transcriptome Profiling Reveals Lack of Acsm3 Expression in Polydactylous Rats with High-Fat Diet-Induced Hypertriglyceridemia and Visceral Fat Accumulation
por: Junková, Kristýna, et al.
Publicado: (2021)